The Common Cold And SARS-CoV-2 Immunity.

No Vaccine Required. Is it possible that the common cold could can provide immunity through memory T cells to a significant proportion of a population? In recent articles we have highlighted various other reasons why a vaccine is not required. This include; those not at risk (that’s over 99%) don’t need one and those at […]

Read More…


Déjà vu – memory T cells have seen SARS-CoV-2 before.

Newly-Discovered Is Not New. In early September we first highlighted the incorrect designation of SARS-CoV-2 as a ‘novel’ or ‘new’ coronavirus when it should have been designated ‘newly-discovered’. There is a subtle but fundamental difference: something that is new did not previously exist whereas something that is newly-discovered already existed but not been discovered yet. […]

Read More…


These Are Not The Drugs You Are Looking For.

Don’t Use Remdesivir. Just one month after the US Food and Drug Administration approved remdesivir as an antiviral for the treatment of patients with COVID-19, the WHO yesterday recommended that it not be used, on the basis that it is ineffective and there is “no evidence” it reduces mortality. Last month, we analysed remdesivir’s use […]

Read More…


Monetising A Vaccine Shows What It’s Really All About.

LOADSAMONEY! According to the sales pitch on Thursday from investment banks Credit Suisse and Morgan Stanley, a COVID-19 vaccine could be a “bumper revenue opportunity“, projected to earn at least $10 billion a year. Morgan Stanley’s projection is at least $10 billion a year across developed countries but Credit Suisse is bigging it up further […]

Read More…


Antivirals – lessons from the ‘flu jab’.

That Time Of Year Again. If you have read the previous two articles then you will know the main differences between a vaccine and an antiviral, and why Remdesivir is not an effective antiviral for just about anyone with COVID-19. We have highlighted that antivirals have a pretty patchy record when it comes to their […]

Read More…


Remdesivir – an antiviral for a specific narrow group but a wonderdrug for everyone else?

Antiviral Not Vaccine. The US Food and Drug Administration (FDA) has given full approval to remdesivir for the treatment of COVID-19.  Remdesivir has been receiving coverage since the early days of the Great Insanity – often touted as a wonderdrug – and has been in use on a compassionate patient-by-patient basis since late January as […]

Read More…


An antiviral maybe but a vaccine isn’t needed and wouldn’t be effective.

Apparently everything now hangs on a vaccine: stockmarkets rise and fall on the mere rumour of how the rumoured development of a particular rumoured COVID-19 vaccine is going; politicians say that normality can’t be resumed until a vaccine is available; people are fed the line that a virus must have a vaccine and that without […]

Read More…